Toward Synthetic Biology 2.0 - Moving beyond genome engineering to whole cell engineering

The pandemic has exposed the cracks in pharma’s supply chain – to fix it, we need an entirely new way to make medicines. In this session, Christina Smolke will share her thoughts on exactly how we can do this with a synthetic-biology-based manufacturing platform that offers a domestic, rapid-response, economical solution to today's drug shortage.